Altogether, our study proposed an interaction approach between CRC cells and MSC-EVs, in which miR-222 derived from MSC-EVs committed the posttranscriptional regulation on ATF3, consequentially activated the AKT pathway and promoted the development of CRC, thereby augmenting tumor growth and immune escape in vivo (Fig. 8). The gene discussed is AKT1; the disease is neoplasm.